These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 222486)
1. Augmentation of specifici immune response against syngeneic SV40-induced tumor-associated antigens by splenectomy. Glaser M Cell Immunol; 1979 Jun; 45(1):230-6. PubMed ID: 222486 [No Abstract] [Full Text] [Related]
2. Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice. Glaser M J Natl Cancer Inst; 1978 Nov; 61(5):1351-5. PubMed ID: 213615 [No Abstract] [Full Text] [Related]
3. Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide. Glaser M Cell Immunol; 1979 Dec; 48(2):339-45. PubMed ID: 228870 [No Abstract] [Full Text] [Related]
4. Antibody response to simian virus 40 tumor antigen in nude mice reconstituted with T cells. Cicurel L; Croce CM J Immunol; 1977 Sep; 119(3):850-4. PubMed ID: 197168 [TBL] [Abstract][Full Text] [Related]
5. Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice. Glaser M J Exp Med; 1979 Mar; 149(3):774-9. PubMed ID: 219129 [TBL] [Abstract][Full Text] [Related]
6. In vitro induction of tumor-specific immunity by highly purified VSV grown in SV40-transformed cells and tumor glycolipids incorporated into liposomes. Ansel S Int J Cancer; 1983 Jun; 31(6):785-90. PubMed ID: 6190766 [TBL] [Abstract][Full Text] [Related]
7. Induction of simian virus 40 (SV40) transplantation immunity in mice by SV40-transformed cells of various species. Law LW; Takemoto KK; Rogers MJ; Ting RC J Natl Cancer Inst; 1977 Nov; 59(5):1523-6. PubMed ID: 198568 [TBL] [Abstract][Full Text] [Related]
8. Generation of cytotoxic lymphocytes by SV40-induced antigens. Chang C; Chang R; Mora PT; Hu CP J Immunol; 1982 May; 128(5):2160-3. PubMed ID: 6278025 [TBL] [Abstract][Full Text] [Related]
9. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection. Newmaster RS; Mylin LM; Fu TM; Tevethia SS Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511 [TBL] [Abstract][Full Text] [Related]
10. Indomethacin-sensitive suppressor cells regulate the cell-mediated cytotoxic response to SV 40-induced tumor-associated antigens in mice. Glaser M Eur J Immunol; 1980 Jul; 10(7):489-95. PubMed ID: 6250855 [No Abstract] [Full Text] [Related]
11. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity. Bright RK; Shearer MH; Kennedy RC J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411 [TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immunity in mice against papain-solubilized histocompatibility and tumor-specific antigens by a macrophage migration inhibition microassay. Maurer BA; Dean JH; McCoy JL; Appella E; Law LW J Natl Cancer Inst; 1976 May; 56(5):1075-8. PubMed ID: 186617 [TBL] [Abstract][Full Text] [Related]
13. Induction of simian virus 40-specific tumour rejection by the Ad2+ND2 hybrid virus. Jay G; Jay FT; Chang C; Levine AS; Friedman RM J Gen Virol; 1979 Aug; 44(2):287-96. PubMed ID: 230283 [TBL] [Abstract][Full Text] [Related]
14. Quantitative in vivo studies of soluble simian virus 40 tumor-specific transplantation antigens of the mouse. Henriksen O; Law LW; Appella E J Natl Cancer Inst; 1977 Jun; 58(6):1785-8. PubMed ID: 194045 [TBL] [Abstract][Full Text] [Related]
15. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice. Law LW; Takemoto KK; Rogers MJ; Henriksen O; Ting RC Int J Cancer; 1978 Sep; 22(3):315-22. PubMed ID: 212373 [TBL] [Abstract][Full Text] [Related]
16. Subcellular distribution of the tumor-specific transplantation antigen of simian virus 40-transformed cells. Rogers MJ; Law LW; Appella E J Natl Cancer Inst; 1977 Oct; 59(4):1291-5. PubMed ID: 198559 [TBL] [Abstract][Full Text] [Related]
17. Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes. Zerrahn J; Utermöhlen O; Warnecke G; Deppert W; Lehmann-Grube F J Immunol; 1996 May; 156(10):3919-24. PubMed ID: 8621931 [TBL] [Abstract][Full Text] [Related]
18. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells. Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701 [TBL] [Abstract][Full Text] [Related]
19. Immune response to polyoma tumor cells in mice. I. Magnitude and specificity of the in vitro cellular cytotoxicity elicited by immunization with graded numbers of tumor cells. Walia AS; Lamon EW J Natl Cancer Inst; 1977 Jun; 58(6):1671-5. PubMed ID: 194042 [No Abstract] [Full Text] [Related]
20. Restoration of specific immunity against SV40 tumor-specific transplantation antigen to lymphoid cells from tumor-bearing mice. Blasecki JW; Tevethia SS Int J Cancer; 1975 Aug; 16(2):275-83. PubMed ID: 51012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]